NeuroOne Medical Technologies Corporation (NMTC) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Eden Prairie, MN, United States. The current CEO is David A. Rosa.
NMTC has IPO date of 2018-03-15, 17 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $37.01M.
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
